Literature DB >> 14642023

Diagnosis and measurement of anxiety disorder in adolescents: a review of commonly used instruments.

Sarah J Brooks1, Stan Kutcher.   

Abstract

As part of a comprehensive review of clinical research tools used in adolescent psychiatric disorders, a survey of 200 recent studies of adolescent anxiety (publication dates of December 1994 to May 2001) identified 70 different diagnostic and symptom measurement instruments. The design features and psychometric properties of the 15 most commonly used instruments were reviewed, and their strengths and weaknesses were evaluated. The conclusions arising from this review are: (1) too many different instruments are being used by investigators; (2) more than 20% of studies did not report the use of developmentally appropriate (i.e., child/adolescent-specific) diagnostic instruments; (3) another 15% of these studies relied on diagnostic instruments that demonstrate substantial weaknesses in reliability and validity; (4) the concordance between anxiety disorder diagnoses from different interview schedules is unknown; (5) the relative validity of diagnoses and ratings of anxiety severity based on information yielded by parents versus information yielded by adolescents is unclear; (6) clinician-rated symptom severity scales specific to anxiety disorder are rarely utilized; (7) the most commonly used self-report measures discriminate poorly between anxiety and depression, and their items are not indexed to specific anxiety disorders; and (8) some newer self-report anxiety instruments discriminate well between anxiety and depression and have diagnostic validity for specific anxiety disorders.

Entities:  

Mesh:

Year:  2003        PMID: 14642023     DOI: 10.1089/104454603322572688

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  7 in total

1.  Use of psychotropic medications in Italian children and adolescents.

Authors:  Antonio Clavenna; Elisa Rossi; Marisa Derosa; Maurizio Bonati
Journal:  Eur J Pediatr       Date:  2006-10-07       Impact factor: 3.183

2.  Validation of the diagnoses of panic disorder and phobic disorders in the US National Comorbidity Survey Replication Adolescent (NCS-A) supplement.

Authors:  Jennifer Greif Green; Shelli Avenevoli; Matthew Finkelman; Michael J Gruber; Ronald C Kessler; Kathleen R Merikangas; Nancy A Sampson; Alan M Zaslavsky
Journal:  Int J Methods Psychiatr Res       Date:  2011-06       Impact factor: 4.035

Review 3.  Evaluation of the methodological quality of systematic reviews of health status measurement instruments.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Paul W Stratford; Jordi Alonso; Donald L Patrick; Ingrid Riphagen; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2009-02-24       Impact factor: 4.147

Review 4.  Evidence based clinical assessment of child and adolescent social phobia: a critical review of rating scales.

Authors:  Bogdan T Tulbure; Aurora Szentagotai; Anca Dobrean; Daniel David
Journal:  Child Psychiatry Hum Dev       Date:  2012-10

5.  Systematic Review of Screening Instruments for Psychosocial Problems in Children and Adolescents With Long-Term Physical Conditions.

Authors:  Hiran Thabrew; Heather McDowell; Katherine Given; Kathryn Murrell
Journal:  Glob Pediatr Health       Date:  2017-02-10

6.  Evaluation of the psychometric properties of a modified version of the Social Phobia Screening Questionnaire for use in adolescents.

Authors:  Malin Gren-Landell; Andreas Björklind; Maria Tillfors; Tomas Furmark; Carl Göran Svedin; Gerhard Andersson
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2009-11-11       Impact factor: 3.033

7.  Comparison of YouthCHAT, an Electronic Composite Psychosocial Screener, With a Clinician Interview Assessment for Young People: Randomized Controlled Trial.

Authors:  Hiran Thabrew; Simona D'Silva; Margot Darragh; Mary Goldfinch; Jake Meads; Felicity Goodyear-Smith
Journal:  J Med Internet Res       Date:  2019-12-03       Impact factor: 5.428

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.